期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

非典型抗精神病药物治疗双相抑郁 被引量：2

Atypical antipsychotics in the treatment of bipolar depression
下载PDF
导出
摘要 双相抑郁是双相障碍的一种发作形式,临床治疗困难。非典型抗精神病药物具有心境稳定作用,目前主要用于治疗双相躁狂,但对双相抑郁的治疗尚有争议。部分非典型抗精神病药物治疗双相抑郁有效。 Bipolar depression is a type of bipolar disorder which is hard to treat. Atypical antipsychotics, which have mood-stabilizing effect, are mainly used to treat bipolar mania, but their influence on bipolar depression remains controversial. Some atypical antipsychotics are effective in the treatment of bipolar depression.
作者 吴彦 杨杰 施慎逊
机构地区 上海交通大学医学院附属精神卫生中心 复旦大学附属华山医院
出处 《上海医药》 CAS 2012年第17期7-9,共3页 Shanghai Medical & Pharmaceutical Journal
关键词 双相抑郁 非典型抗精神病药物 治疗 bipolar depression atypical antipsychotics treatment
分类号 R749.4 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献14

  • 1Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression [J]. N Engl J Med, 2007, 356(17): 1711-1722.
  • 2Yatham LN, Kennedy SH, Schaffer A, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009 [J]. Bipolar Disord, 2009, 11(3): 225-255.
  • 3Kasper S, Calabrese JR, Johnson G, et al . International Consensus Group on the evidence-based pharmacologic treatment of bipolar I and II depression [J]. J Clin Psychiatry, 2008, 69(10): 1632-1646.
  • 4Grunze H, Vieta E, Goodwin GM, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: update 2010 on the treatment of acute bipolar depression [J]. World J Biol Psychiatry, 2010, 11(2): 81-109.
  • 5Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression [J]. Arch Gen Psychiatry, 2003, 60(11): 1079-1088.
  • 6Calabrese JR, Keck PE Jr, Macfadden W, et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression [J]. Am J Psychiatry, 2005, 162(7): 1351-1360.
  • 7Thase ME, Macfadden W, Weisler RH, et al. Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study) [J]. J Clin Psychopharmacol, 2006, 26(6): 600-609.
  • 8Young AH, McElroy SL, Bauer M, et al. A double- blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I) [J]. J Clin Psychiatry, 2010, 71(2):150-162.
  • 9McElroy SL, Weisler RH, Chang W, et al. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II) [J]. J Clin Psychiatry, 2010, 71(2): 163-174.
  • 10Suppes T, Datto C, Minkwitz M, et al. Effectiveness of the extended release formulation of quetiapine as monotherapy for the treatment of acute bipolar depression [J]. J Affect Disord, 2010, 121(1-2): 106-115.

同被引文献20

  • 1金卫东,陈炯,王鹤秋,马永春,陈正昕,张江涛,邢葆平.抗抑郁药物引起双相抑郁患者转相的单因素研究及回归分析[J].中国行为医学科学,2007,16(5):416-417. 被引量：6
  • 2American Psychiatry Association. Practice for the treat- ment of patients guideline with bipolar disorder ( Revi- sion) [ J ]. Am J Psychiatry, 2002,159 ( suppl4 ) : 1-50.
  • 3Yatham L N, Goldstein J, Vieta E, et al. Atypical antip- sychotics in bipolar depression:potential mechanisnm of action [ J ]. Clin Psychiatr ,2005,66 ( Suppl 5 ) :40-48.
  • 4Hideaki K, Yasusbi T, Mauricio T, et al. Efficacy and safety of olanzapinc in the treatment of Japanese patients withbipolar I disorder in a current manic or mixed epi- sode : a randomized, double-blind, placebo- andhaloperi- dol-controlled study [ J ]. J Affect Disord, 2012, 136 (3) : 476-484.
  • 5Todd M. Valproate or olanzapine add-on to lithium: An 8-week, randomized, open-label study in Italian patients with a manic relapse[J]. J Affect Disord, 2007,99( 1- 3 ) : 247-251.
  • 6Judith W, Alastair F, Barnett M, et al. Factors associ- ated with non-completion in a double-blind randomized controlled trial of olanzapine plus sertraline versus olanzapine plus placebo for psychotic depression [ J ].Psychiatry Research, 2012,197 ( 3 ) : 221-226.
  • 7Todd M. Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling[J]. J Affect Dis- ord, 2003,73(1) : 155-161.
  • 8Tohen, M, McDonnell D P, Case M, et al. A Random- ised, double-blind, placebo-controlled study of olanzap- ine in patients with bipolar I depression [ J ]. Brit J Pharmacol,2011, 3:376-382.
  • 9Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzap- ine and olanzapine- fluoxetine combinationin the treatment of bipolar I depression [J]. Archi of Gene Psych,2011,60: 1079-1088.
  • 10Hirose S, Ashby C R. An open pilot study combining risperidoneand a selective serotonin reuptake inhibitor as initial antidepres-sant therapy [ J ]. Clin Psychiatry, 2002,63:733-736.

引证文献2

二级引证文献9

上海医药
2012年 第17期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部